Cargando…

Integrated Cancer Treatment in the Course of Metastatic Pancreatic Cancer: Complete Resolution in 2 Cases

Pancreatic cancer (PC) has a very low average survival, but its prognosis is further reduced in the case of metastatic spread. Medical therapy in these cases is the only applicable methodology in the international guidelines. During anticancer treatments, common side effects are nausea, vomiting, ar...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bonucci, Massimo, Pastore, Carlo, Ferrera, Vincenzo, Fiorentini, Carla, Fabbri, Alessia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2018
Materias:	Case Studies
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6142071/ https://www.ncbi.nlm.nih.gov/pubmed/29478350 http://dx.doi.org/10.1177/1534735418755479

Ejemplares similares

Hyperthermia combined with chemotherapy vs chemotherapy in patients with advanced pancreatic cancer: A multicenter retrospective observational comparative study
por: Fiorentini, Giammaria, et al.
Publicado: (2023)

Modulated electro-hyperthermia in stage III and IV pancreatic cancer: Results of an observational study on 158 patients
por: Fiorentini, Giammaria, et al.
Publicado: (2021)

The Rho-activating CNF1 toxin from pathogenic E. coli: A risk factor for human cancer development?
por: Travaglione, Sara, et al.
Publicado: (2008)

The Combination of AHCC and ETAS Decreases Migration of Colorectal Cancer Cells, and Reduces the Expression of LGR5 and Notch1 Genes in Cancer Stem Cells: A Novel Potential Approach for Integrative Medicine
por: Paganelli, Francesca, et al.
Publicado: (2021)

Raltitrexed–eloxatin salvage chemotherapy in gemcitabine-resistant metastatic pancreatic cancer
por: Reni, M, et al.
Publicado: (2006)

Integrative Hematology: State of the Art
por: Andreazzoli, Francesca, et al.
Publicado: (2023)

The Cytotoxic Necrotizing Factor 1 from E. Coli: A Janus Toxin Playing with Cancer Regulators
por: Fabbri, Alessia, et al.
Publicado: (2013)

Comparison of gemcitabine plus nab-paclitaxel and FOLFIRINOX in metastatic pancreatic cancer
por: Han, Sung Yong, et al.
Publicado: (2020)

Escherichia coli Cytotoxic Necrotizing Factor 1 (CNF1): Toxin Biology, in Vivo Applications and Therapeutic Potential
por: Fabbri, Alessia, et al.
Publicado: (2010)

Phase I trial of oral S-1 combined with gemcitabine in metastatic pancreatic cancer
por: Nakamura, K, et al.
Publicado: (2005)

Phase II trial of oral S-1 combined with gemcitabine in metastatic pancreatic cancer
por: Nakamura, K, et al.
Publicado: (2006)

Circulating cytokines and outcome in metastatic colorectal cancer patients treated with regorafenib
por: Ricci, Vincenzo, et al.
Publicado: (2020)

Polyethylene glycol microspheres loaded with irinotecan for arterially directed embolic therapy of metastatic liver cancer
por: Fiorentini, Giammaria, et al.
Publicado: (2017)

Integrating TYMS, KRAS and BRAF testing in patients with metastatic colorectal cancer
por: Ntavatzikos, Anastasios, et al.
Publicado: (2017)

Gut Microbiota and Colon Cancer: A Role for Bacterial Protein Toxins?
por: Fiorentini, Carla, et al.
Publicado: (2020)

Complete Resolution of Metastatic Gallbladder Cancer after Standard Gemcitabine-Cisplatin Combination Therapy
por: Rho, Young Soo, et al.
Publicado: (2015)

Bioactive Immunomodulatory Compounds: A Novel Combinatorial Strategy for Integrated Medicine in Oncology? BAIC Exposure in Cancer Cells
por: Corradetti, Bruna, et al.
Publicado: (2019)

KRAS mutation detection by high-resolution melting analysis significantly predicts clinical benefit of cetuximab in metastatic colorectal cancer
por: Malapelle, U, et al.
Publicado: (2012)

Bone Targeting Agents in Patients with Metastatic Prostate Cancer: State of the Art
por: Mollica, Veronica, et al.
Publicado: (2021)

An Unusual Course of Metastatic Gastroesophageal Cancer
por: Smith, William H., et al.
Publicado: (2015)

Multicentre phase II trial of trastuzumab and capecitabine in patients with HER2 overexpressing metastatic pancreatic cancer
por: Harder, J, et al.
Publicado: (2012)

Dose escalation to rash for erlotinib plus gemcitabine for metastatic pancreatic cancer: the phase II RACHEL study
por: Van Cutsem, E, et al.
Publicado: (2014)

Final analysis of a phase II study of modified FOLFIRINOX in locally advanced and metastatic pancreatic cancer
por: Stein, Stacey M, et al.
Publicado: (2016)

Cell-to-Cell Propagation of the Bacterial Toxin CNF1 via Extracellular Vesicles: Potential Impact on the Therapeutic Use of the Toxin
por: Fabbri, Alessia, et al.
Publicado: (2015)

Second-line therapy after nab-paclitaxel plus gemcitabine or after gemcitabine for patients with metastatic pancreatic cancer
por: Chiorean, E Gabriela, et al.
Publicado: (2016)

Modulated Electro-Hyperthermia as Palliative Treatment for Pancreatic Cancer: A Retrospective Observational Study on 106 Patients
por: Fiorentini, Giammaria, et al.
Publicado: (2019)

Pancreatic Head Mass from Metastatic Meningeal Hemangiopericytoma
por: Teh, Bin S., et al.
Publicado: (2000)

Clinical course of ulcerative colitis patients who develop acute pancreatitis
por: Kim, Jong Wook, et al.
Publicado: (2017)

Pancreatic Cancer Malnutrition and Pancreatic Exocrine Insufficiency in the Course of Chemotherapy in Unresectable Pancreatic Cancer
por: Kiriukova, Mariia, et al.
Publicado: (2020)

The course of metastatic prostate cancer under treatment
por: Demir, Aslan, et al.
Publicado: (2014)

Cetuximab plus gemcitabine/oxaliplatin (GEMOXCET) in first-line metastatic pancreatic cancer: a multicentre phase II study
por: Kullmann, F, et al.
Publicado: (2009)

The E. coli CNF1 as a Pioneering Therapy for the Central Nervous System Diseases
por: Travaglione, Sara, et al.
Publicado: (2014)

Effects of the Escherichia coli Bacterial Toxin Cytotoxic Necrotizing Factor 1 on Different Human and Animal Cells: A Systematic Review
por: Carlini, Francesca, et al.
Publicado: (2021)

FOLFIRINOX vs gemcitabine/nab-paclitaxel for treatment of metastatic pancreatic cancer: Single-center cohort study
por: Cho, In Rae, et al.
Publicado: (2020)

Prognosis of metastatic breast cancer: are there differences between patients with de novo and recurrent metastatic breast cancer?
por: Lobbezoo, D J A, et al.
Publicado: (2015)

High-Resolution Magnetic Resonance Imaging Quantitatively Detects Individual Pancreatic Islets
por: Lamprianou, Smaragda, et al.
Publicado: (2011)

Modulated Electrohyperthermia in Integrative Cancer Treatment for Relapsed Malignant Glioblastoma and Astrocytoma: Retrospective Multicenter Controlled Study
por: Fiorentini, Giammaria, et al.
Publicado: (2018)

Folfirinox versus gemcitabine/nab-paclitaxel as first-line therapy in patients with metastatic pancreatic cancer: a comparative propensity score study
por: Williet, Nicolas, et al.
Publicado: (2019)

First-line chemotherapy in very elderly patients with metastatic pancreatic cancer: Gemcitabine monotherapy vs combination chemotherapy
por: Han, Sung Yong, et al.
Publicado: (2020)

Transcriptome analysis of the procession from chronic pancreatitis to pancreatic cancer and metastatic pancreatic cancer
por: Tu, Jihao, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_3og55v9464n1t6keanhhu54p2v